These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 25456120)

  • 1. iPSC-derived dopamine neurons reveal differences between monozygotic twins discordant for Parkinson's disease.
    Woodard CM; Campos BA; Kuo SH; Nirenberg MJ; Nestor MW; Zimmer M; Mosharov EV; Sulzer D; Zhou H; Paull D; Clark L; Schadt EE; Sardi SP; Rubin L; Eggan K; Brock M; Lipnick S; Rao M; Chang S; Li A; Noggle SA
    Cell Rep; 2014 Nov; 9(4):1173-82. PubMed ID: 25456120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A New Glucocerebrosidase Chaperone Reduces α-Synuclein and Glycolipid Levels in iPSC-Derived Dopaminergic Neurons from Patients with Gaucher Disease and Parkinsonism.
    Aflaki E; Borger DK; Moaven N; Stubblefield BK; Rogers SA; Patnaik S; Schoenen FJ; Westbroek W; Zheng W; Sullivan P; Fujiwara H; Sidhu R; Khaliq ZM; Lopez GJ; Goldstein DS; Ory DS; Marugan J; Sidransky E
    J Neurosci; 2016 Jul; 36(28):7441-52. PubMed ID: 27413154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ER Stress and Autophagic Perturbations Lead to Elevated Extracellular α-Synuclein in GBA-N370S Parkinson's iPSC-Derived Dopamine Neurons.
    Fernandes HJ; Hartfield EM; Christian HC; Emmanoulidou E; Zheng Y; Booth H; Bogetofte H; Lang C; Ryan BJ; Sardi SP; Badger J; Vowles J; Evetts S; Tofaris GK; Vekrellis K; Talbot K; Hu MT; James W; Cowley SA; Wade-Martins R
    Stem Cell Reports; 2016 Mar; 6(3):342-56. PubMed ID: 26905200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-Cell Sequencing of iPSC-Dopamine Neurons Reconstructs Disease Progression and Identifies HDAC4 as a Regulator of Parkinson Cell Phenotypes.
    Lang C; Campbell KR; Ryan BJ; Carling P; Attar M; Vowles J; Perestenko OV; Bowden R; Baig F; Kasten M; Hu MT; Cowley SA; Webber C; Wade-Martins R
    Cell Stem Cell; 2019 Jan; 24(1):93-106.e6. PubMed ID: 30503143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation and characterization of human-derived iPSC lines from three pairs of monozygotic twins discordant for Parkinson's disease.
    Dulovic-Mahlow M; Lukomska A; Diaw SH; Balck A; Borsche M; Grütz K; Lenz I; Rudolph F; Lohmann K; Klein C; Seibler P
    Stem Cell Res; 2019 Dec; 41():101629. PubMed ID: 31706098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced Pluripotent Stem Cell-Derived Dopaminergic Neurons from Familial Parkinson's Disease Patients Display α-Synuclein Pathology and Abnormal Mitochondrial Morphology.
    Diao X; Wang F; Becerra-Calixto A; Soto C; Mukherjee A
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoamine oxidase and α-synuclein as targets in Parkinson's disease therapy.
    Follmer C
    Expert Rev Neurother; 2014 Jun; 14(6):703-16. PubMed ID: 24852232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. α-Synuclein stimulation of monoamine oxidase-B and legumain protease mediates the pathology of Parkinson's disease.
    Kang SS; Ahn EH; Zhang Z; Liu X; Manfredsson FP; Sandoval IM; Dhakal S; Iuvone PM; Cao X; Ye K
    EMBO J; 2018 Jun; 37(12):. PubMed ID: 29769405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical Characteristics of iPSC-Derived Dopaminergic Neurons from N370S
    Grigor'eva EV; Kopytova AE; Yarkova ES; Pavlova SV; Sorogina DA; Malakhova AA; Malankhanova TB; Baydakova GV; Zakharova EY; Medvedev SP; Pchelina SN; Zakian SM
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901867
    [No Abstract]   [Full Text] [Related]  

  • 10. Modeling Parkinson's Disease Using Patient-specific Induced Pluripotent Stem Cells.
    Li H; Jiang H; Zhang B; Feng J
    J Parkinsons Dis; 2018; 8(4):479-493. PubMed ID: 30149462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Small GTPase RAC1/CED-10 Is Essential in Maintaining Dopaminergic Neuron Function and Survival Against α-Synuclein-Induced Toxicity.
    Kim H; Calatayud C; Guha S; Fernández-Carasa I; Berkowitz L; Carballo-Carbajal I; Ezquerra M; Fernández-Santiago R; Kapahi P; Raya Á; Miranda-Vizuete A; Lizcano JM; Vila M; Caldwell KA; Caldwell GA; Consiglio A; Dalfo E
    Mol Neurobiol; 2018 Sep; 55(9):7533-7552. PubMed ID: 29429047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct targeting of wild-type glucocerebrosidase by antipsychotic quetiapine improves pathogenic phenotypes in Parkinson's disease models.
    Burbulla LF; Zheng J; Song P; Jiang W; Johnson ME; Brundin P; Krainc D
    JCI Insight; 2021 Oct; 6(19):. PubMed ID: 34622801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptome Analysis of Induced Pluripotent Stem Cells and Neuronal Progenitor Cells, Derived from Discordant Monozygotic Twins with Parkinson's Disease.
    Vlasov IN; Alieva AK; Novosadova EV; Arsenyeva EL; Rosinskaya AV; Partevian SA; Grivennikov IA; Shadrina MI
    Cells; 2021 Dec; 10(12):. PubMed ID: 34943986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SNCA triplication Parkinson's patient's iPSC-derived DA neurons accumulate α-synuclein and are susceptible to oxidative stress.
    Byers B; Cord B; Nguyen HN; Schüle B; Fenno L; Lee PC; Deisseroth K; Langston JW; Pera RR; Palmer TD
    PLoS One; 2011; 6(11):e26159. PubMed ID: 22110584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons.
    Decressac M; Mattsson B; Lundblad M; Weikop P; Björklund A
    Neurobiol Dis; 2012 Mar; 45(3):939-53. PubMed ID: 22182688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endosomal dysfunction in iPSC-derived neural cells from Parkinson's disease patients with VPS35 D620N.
    Bono K; Hara-Miyauchi C; Sumi S; Oka H; Iguchi Y; Okano HJ
    Mol Brain; 2020 Oct; 13(1):137. PubMed ID: 33032646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful function of autologous iPSC-derived dopamine neurons following transplantation in a non-human primate model of Parkinson's disease.
    Hallett PJ; Deleidi M; Astradsson A; Smith GA; Cooper O; Osborn TM; Sundberg M; Moore MA; Perez-Torres E; Brownell AL; Schumacher JM; Spealman RD; Isacson O
    Cell Stem Cell; 2015 Mar; 16(3):269-74. PubMed ID: 25732245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-translational proteomics platform identifies neurite outgrowth impairments in Parkinson's disease GBA-N370S dopamine neurons.
    Bogetofte H; Ryan BJ; Jensen P; Schmidt SI; Vergoossen DLE; Barnkob MB; Kiani LN; Chughtai U; Heon-Roberts R; Caiazza MC; McGuinness W; Márquez-Gómez R; Vowles J; Bunn FS; Brandes J; Kilfeather P; Connor JP; Fernandes HJR; Caffrey TM; Meyer M; Cowley SA; Larsen MR; Wade-Martins R
    Cell Rep; 2023 Mar; 42(3):112180. PubMed ID: 36870058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of an induced pluripotent stem cell line (CSC-46) from a patient with Parkinson's disease carrying a novel p.R301C mutation in the GBA gene.
    Gustavsson N; Marote A; Pomeshchik Y; Russ K; Azevedo C; Chumarina M; Goldwurm S; Collin A; Pinto L; Salgado AJ; Klementieva O; Roybon L; Savchenko E
    Stem Cell Res; 2019 Jan; 34():101373. PubMed ID: 30640063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induced pluripotent stem cell (iPSC)-derived dopaminergic models of Parkinson's disease.
    Beevers JE; Caffrey TM; Wade-Martins R
    Biochem Soc Trans; 2013 Dec; 41(6):1503-8. PubMed ID: 24256244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.